Regeneron

Regeneron anticoagulant bests enoxaparin, matches Eliquis in phase 2 trial
Fierce Biotech
Thu, 12/19/24 - 11:31 am
Regeneron
REGN7508
anticoagulants
enoxaparin
Eliquis
clinical trials
Regeneron, Bayer Build Retinal Vein Occlusion Case for Eylea as Biosimilar Pressure Mounts
BioSpace
Wed, 12/18/24 - 11:12 am
Regeneron
Bayer
retinal vein occlusion
Eyelea
Regeneron’s R&D approach scores dual wins against Alexion’s Ultomiris and in lymphoma
Pharma Voice
Thu, 12/12/24 - 11:33 am
ASH 2024
Regeneron
lymphoma
Alexion
Ultomiris
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
Benzinga
Fri, 11/15/24 - 11:15 am
Regeneron
Sanofi
Dupixent
FDA
chronic spontaneous urticaria
Regeneron Reports Mixed Q3 Sales as Eylea Franchise Remains Under Pressure
BioSpace
Fri, 11/1/24 - 10:54 am
Regeneron
Eylea
earnings
Regeneron loses bid to block Amgen's Eylea biosimilar launch in US
Reuters
Tue, 10/22/24 - 11:30 pm
Regeneron
Amgen
biosimilars
Eylea
Regeneron takes the long-haul approach to oncology, stumbles and all
Pharma Voice
Thu, 10/10/24 - 09:52 am
Regeneron
cancer
oncology
Libtayo
FDA, after delay, clears Regeneron and Sanofi drug for COPD
BioPharma Dive
Mon, 09/30/24 - 09:25 am
Regeneron
Sanofi
Dupixent
COPD
FDA
Sanofi's Dupixent scores double COPD win in US, China
Pharmaphorum
Mon, 09/30/24 - 09:16 am
Sanofi
Regeneron
Dupixent
COPD
China
Regeneron's stock drops as it loses bid to block Amgen's Eylea biosimilar
Fierce Pharma
Tue, 09/24/24 - 11:56 am
Regeneron
Amgen
legal
biosimilars
Eylea
ESMO 2024: Regeneron’s melanoma combo therapy benefit continues beyond two years
Clinical Trials Arena
Mon, 09/16/24 - 09:46 am
ESMO
Regeneron
melanoma
clinical trials
fiablimab
Radiant Bio closes $35 million Series A funding for antibody platform
Citybiz
Wed, 09/11/24 - 11:48 am
Radiant Bio
funding
GSK
Regeneron
antibody platform
3 FDA approval dates to watch in the year’s final push
Pharma Voice
Wed, 09/11/24 - 11:39 am
FDA
Bristol Myers Squibb
KarXT
schizophrenia
Regeneron
Sanofi
Dupixent
COPD
BridgeBio
acoramidis
ATTR cardiomyopathy
Dupixent succeeds in chronic hives study, giving Sanofi, Regeneron a chance to rebound
BioPharma Dive
Wed, 09/11/24 - 11:19 am
Dupixent
chronic hives
Sanofi
Regeneron
FDA
Regeneron joins Koneksa Parkinson's digital biomarker study
Pharmaphorum
Wed, 09/4/24 - 11:22 am
Regeneron
Koneska Health
digital biomarkers
Parkinson's Disease
Merck
After FDA rejection, Regeneron gains nod in Europe for T-cell engager odronextamab
Fierce Pharma
Mon, 08/26/24 - 11:20 am
Regeneron
Europe
FDA
Ordspono
bispecifics
T-cell engager
FDA declines to approve Regeneron's blood cancer therapy
Reuters
Tue, 08/20/24 - 09:59 pm
Regeneron
FDA
linvoseltamab
Multiple Myeloma
BioNTech, Regeneron’s mRNA Cancer Vaccine Combo Clears Phase II in Melanoma
BioSpace
Tue, 07/30/24 - 11:41 am
BioNTech
Regeneron
Merck
Moderna Therapeutics
mRNA-4157/V940
melanoma
7 years after launch, Sanofi’s Dupixent is set for a megablockbuster run
Pharma Voice
Tue, 07/30/24 - 11:30 am
Sanofi
Regeneron
Dupixent
Trials to watch: Four biologics concluding pivotal COPD trials
Clinical Trials Arena
Thu, 07/25/24 - 11:36 am
COPD
biologics
clinical trials
GSK
Nucala
AstraZeneca
Fasenra
Roche
astegolimab
Sanofi
Regeneron
Dupixent

Pages